USC

InVivo Therapeutics Announces Enrollment of Fifth Patient in Pilot Spinal Cord Injury Study

CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that the fifth patient has been enrolled in the company’s ongoing pilot…